Baillie Gifford & Co
CLOV icon

Baillie Gifford & Co’s Clover Health Investments CLOV Stock Holding History

Baillie Gifford & Co’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,645,503
Closed -$2.46M – 459
2022
Q4 		$2.46M Hold
2,645,503
– – ﹤0.01% 258
2022
Q3 		$4.5M Hold
2,645,503
– – ﹤0.01% 240
2022
Q2 		$5.66M Sell
2,645,503
-5,142,177
-66% -$13.7M 0.01% 229
2022
Q1 		$27.6M Hold
7,787,680
– – 0.02% 195
2021
Q4 		$29M Buy
7,787,680
+2,645,503
+51% +$16.2M 0.02% 206
2021
Q3 		$38M Hold
5,142,177
– – 0.02% 201
2021
Q2 		$68.5M Hold
5,142,177
– – 0.03% 168
2021
Q1 		$38.9M Buy
+5,142,177
New +$58M 0.02% 197

Other funds holding CLOV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return